Invitae boosted its genetic testing menu with a new test for the diagnosis of spinal muscular atrophy, the second-leading genetic disease in infants. The test provides “significant improvements” over ...

University of Iowa to use Bionano-based assay to replace most “gold standard” Southern blot tests for molecular diagnosis of FSHD SAN DIEGO, April 22, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc.

The Massachusetts Department of Public Health is preparing a pilot program to screen newborns for a rare but often fatal disease: spinal muscular atrophy, or SMA. Last month, the Missouri Legislature ...

The clinical distinction between myopathic and neurogenic disorders of the motor unit is often difficult, since both lesions appear as flaccid, areflexic paralyses, often with variable muscular ...

July 26 (UPI) --A new test could speed the diagnosis of spinal muscular atrophy, a rare but deadly progressive muscle-wasting disorder, in infants. And a new way to screen for urinary tract infections ...

The mutation that causes Spinal Muscular Atrophy (SMA) can be detected in a prenatal screen. But a parent's decision to test for this terrible disease is not as easy as you would think. Families that ...

Early detection is critical for combating Duchenne muscular dystrophy. In today's Academic Minute, part of University at Albany Week, Bijan Dey looks into better testing methods. Dey is a principal ...

Duchenne muscular dystrophy (DMD) is a rare, incurable condition that typically begins in early childhood and is marked by worsening muscle weakness. The disease results from changes in a gene ...